Skip to main content
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
STATISTICAL BRIEF #137:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
August 2006 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Steven R. Machlin, MS and Kelly Carper, MEd |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Highlights
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
IntroductionUpper respiratory infections are common in children, and inappropriate treatment of these infections with an antibiotic is a public health concern. In particular, inappropriate use can have a negative impact on the effectiveness of antibiotics and increase the risk of infection with a drug-resistant pathogen.* The Michigan Quality Improvement Consortium recommends the following treatment of acute pharyngitis in children:†
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FindingsOn average during 2002-2004, contact was made with a health professional regarding a primary sore throat condition within a 12-month period for 14.0 percent of children under 18 years of age (figure 1). Of these children, over two-thirds (69.7 percent) were prescribed antibiotics to treat their sore throat. Approximately one of every five children (22.0 percent) who were prescribed an antibiotic did not receive a throat swab before receiving the prescription. Age The likelihood of contact with a health professional for a serious sore throat varied by age, ranging from 10.2 percent for children under age 5 to 16.5 percent for children 5-12 years of age (figure 2). Teenage children 13-17 years of age were less likely to have an antibiotic prescribed for a sore throat than younger children (65.3 percent versus 71.1-72.4 percent for the younger age groups). Children 5-12 years of age who were prescribed an antibiotic were more likely to have a throat swab before the prescription (81.7 percent) than younger (70.1 percent) or older (76.5 percent) children. Race/ethnicity White non-Hispanic children were most likely (16.6 percent), and black non-Hispanic children were least likely (7.9 percent) to have contact with a health professional regarding a serious sore throat (figure 3). While there was no significant variation by race/ethnicity in the likelihood of being prescribed an antibiotic, white non-Hispanic children were significantly more likely to have had a throat swab before prescription than Hispanic children (80.5 versus 72.1 percent). Differences between white children and the other two race/ethnicity groups were not statistically significant. Insurance status Children with private insurance were more likely to have contact with a health professional for a serious sore throat (15.3 percent) than those with public only insurance (12.2 percent) or uninsured children (10.4 percent) (figure 4). Uninsured children were less likely to have an antibiotic prescribed for a sore throat (64.2 percent) than children with public only insurance (72.9 percent). Children with private insurance were more likely to have a throat swab prior to an antibiotic prescription (80.8 percent) than children covered by public only insurance (70.9 percent). Region Children in the West were less likely than children in other regions to have contact with a health professional regarding a serious sore throat (11.1 percent versus 13.6-17.4 percent) (figure 5). Children in the South were most likely (74.7 percent) to have an antibiotic prescribed for treatment of a sore throat, and children in the Northeast were most likely to have a throat swab before prescription (85.4 percent). Metropolitan versus nonmetropolitan area The likelihood of contact with a health professional for a serious sore throat was not significantly different for children living in metropolitan statistical areas (MSA) and those living in other areas. Children in MSAs with sore throats were less likely to be prescribed an antibiotic (67.8 percent) than children in non-MSA areas (77.6 percent) but were more likely to have a throat swab before a prescription (81.1 percent) than children in non-MSA areas (66.5 percent) (figure 6). |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Data SourceThe estimates in this Statistical Brief are based on data from the MEPS 2002 Full Year Consolidated Data File (HC-070), the MEPS 2003 Full Year Consolidated Data File (HC-079), and the MEPS 2004 Full Year Population Characteristics Data File (HC-082). |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DefinitionsSore throat survey questions Beginning in 2000, a series of questions were asked in the MEPS Quality Priority Conditions Supplement about the prevalence and treatment of sore throats for children under 18 years of age. The estimates in this brief are based on responses to the following questions from this supplement: Let's talk about the last time (PERSON) had a sore throat that was serious enough to cause you to contact a doctor or other health professional.
Racial and ethnic classifications Classification by race and ethnicity is based on information reported for each family member. Respondents were asked if each family member was Hispanic or Latino. Respondents were also asked which race or races best describes each family member. Race categories include white, black/African American, American Indian or Alaska Native, Asian, Native Hawaiian or other Pacific Islander, and other. Based on these questions, sample persons were classified into the following four race/ethnicity categories: Hispanic or Latino, white non-Hispanic or Latino single race, black non-Hispanic or Latino single race, and other single race or multiple races non-Hispanic or Latino. Health insurance status Children were classified in the following three insurance categories, based on household responses to health insurance status questions:
Areas designated by the U.S. Office of Management and Budget that are composed of a large population nucleus combined with adjacent communities that have a high degree of economic and social integration with the nucleus. An MSA has one or more central counties containing the area's main population concentration. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
About MEPS-HCMEPS-HC is a nationally representative longitudinal survey that collects detailed information on health care utilization and expenditures, health insurance, and health status, as well as a wide variety of social, demographic, and economic characteristics for the civilian noninstitutionalized population. It is cosponsored by the Agency for Healthcare Research and Quality and the National Center for Health Statistics. For more information about MEPS, call the MEPS information coordinator at AHRQ (301-427-1656) or visit the MEPS Web site at http://www.meps.ahrq.gov/. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ReferencesFor a detailed description of the MEPS survey design, sample design, and methods used to minimize sources of nonsampling error, see the following publications:Cohen, J. Design and Methods of the Medical Expenditure Panel Survey Household Component. MEPS Methodology Report No. 1. AHCPR Pub. No. 97-0026. Rockville, Md.: Agency for Health Care Policy and Research, 1997. Cohen, S. Sample Design of the 1996 Medical Expenditure Panel Survey Household Component. MEPS Methodology Report No. 2. AHCPR Pub. No. 97-0027. Rockville, Md.: Agency for Health Care Policy and Research, 1997. Cohen, S. Design Strategies and Innovations in the Medical Expenditure Panel Survey. Medical Care, July 2003: 41(7) Supplement: III-5-III-12. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Suggested CitationMachlin, S. R. and Carper, K. Treatment of Sore Throats: Antibiotic Prescriptions and Throat Cultures for Children under 18 Years of Age, 2002-2004 (Average Annual). Statistical Brief #137. August 2006. Agency for Healthcare Research and Quality, Rockville, Md. http://www.meps.ahrq.gov/mepsweb/data_files/publications/st137/stat137.shtml AHRQ welcomes questions and comments from readers of this publication who are interested in obtaining more information about access, cost, use, financing, and quality of health care in the United States. We also invite you to tell us how you are using this Statistical Brief and other MEPS data and tools and to share suggestions on how MEPS products might be enhanced to further meet your needs. Please e-mail us at mepspd@ahrq.gov or send a letter to the address below: Steven B. Cohen, PhD, Director Center for Financing, Access, and Cost Trends Agency for Healthcare Research and Quality 540 Gaither Road Rockville, MD 20850 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Footnotes* National Committee for Quality Assurance (NCQA): The State of Health Care Quality 2004; HEDIS Measures; Appropriate Testing for Children with Pharyngitis. http://www.ncqa.org/tabid/346/Default.aspx |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
† Michigan Quality Improvement Consortium. Acute pharyngitis in children. Southfield (MI): Michigan Quality Improvement Consortium; 2004 Apr. 1 page. NGC: 004557. http://www.guideline.gov/summary/summary.aspx?doc_id=13823 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|